Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Dec;20(6):850–851. doi: 10.1128/aac.20.6.850

In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.

V I Ahonkhai, C E Cherubin, M F Sierra, V D Bokkenheuser, M A Shulman, A C Mosenthal
PMCID: PMC181813  PMID: 6459767

Abstract

The activities of 11 antimicrobial agents against 36 strains of Campylobacter fetus subsp. jejuni were studied by a broth microdilution method. All strains were susceptible to 7 of the 11 antimicrobial agents. Of the newer agents tested N-formimidoyl thienamycin (MK0787) and rosaramicin had very good activity, whereas cefotaxime, moxalactam, and cefoperazone had poorer activity.

Full text

PDF
850

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chow A. W., Patten V., Bednorz D. Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrob Agents Chemother. 1978 Mar;13(3):416–418. doi: 10.1128/aac.13.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cooper I. A., Slee K. J. Human infection by Vibrio fetus. Med J Aust. 1971 Jun 12;1(24):1263–1267. doi: 10.5694/j.1326-5377.1971.tb92386.x. [DOI] [PubMed] [Google Scholar]
  3. Davies J. S., Penfold J. B. Campylobacter urinary infection. Lancet. 1979 May 19;1(8125):1091–1092. doi: 10.1016/s0140-6736(79)92995-7. [DOI] [PubMed] [Google Scholar]
  4. Grant I. H., Richardson N. J., Bokkenheuser V. D. Broiler chickens as potential source of Campylobacter infections in humans. J Clin Microbiol. 1980 May;11(5):508–510. doi: 10.1128/jcm.11.5.508-510.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Karmali M. A., De Grandis S., Fleming P. C. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother. 1981 Apr;19(4):593–597. doi: 10.1128/aac.19.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Karmali M. A., Fleming P. C. Campylobacter enteritis. Can Med Assoc J. 1979 Jun 23;120(12):1525–1532. [PMC free article] [PubMed] [Google Scholar]
  7. Kesado T., Hashizume T., Asahi Y. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Antimicrob Agents Chemother. 1980 Jun;17(6):912–917. doi: 10.1128/aac.17.6.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mertens A., De Smet M. Campylobacter cholecystitis. Lancet. 1979 May 19;1(8125):1092–1093. doi: 10.1016/s0140-6736(79)92997-0. [DOI] [PubMed] [Google Scholar]
  9. Rettig P. J. Campylobacter infections in human beings. J Pediatr. 1979 Jun;94(6):855–864. doi: 10.1016/s0022-3476(79)80202-4. [DOI] [PubMed] [Google Scholar]
  10. Vanhoof R., Gordts B., Dierickx R., Coignau H., Butzler J. P. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother. 1980 Jul;18(1):118–121. doi: 10.1128/aac.18.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Vanhoof R., Vanderlinden M. P., Dierickx R., Lauwers S., Yourassowsky E., Butzler J. P. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother. 1978 Oct;14(4):553–556. doi: 10.1128/aac.14.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Waitz J. A., Drube C. G., Moss E. L., Jr, Weinstein M. J. Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic. J Antibiot (Tokyo) 1972 Nov;25(11):647–652. doi: 10.7164/antibiotics.25.647. [DOI] [PubMed] [Google Scholar]
  13. Wright E. P. Meningism associated with Campylobacter jejuni enteritis. Lancet. 1979 May 19;1(8125):1092–1092. doi: 10.1016/s0140-6736(79)92996-9. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES